ESALF Stock Latest News

Eisai Co. Advances Cancer Treatment with E7389 Liposomal Study

PremiumCompany Announcements

3d ago

Eisai’s Lemborexant Study: A New Hope for Insomnia Treatment?

PremiumCompany Announcements

15d ago

Eisai’s Fycompa Safety Study: A Potential Game-Changer in Epilepsy Treatment

PremiumCompany Announcements

21d ago

Eisai Co’s Strategic Initiatives and Growth Justify Buy Rating Despite Leqembi Guidance Concerns

PremiumRatings

2M ago

PremiumCompany AnnouncementsEisai Co. Surpasses FY 2024 Expectations Amid Challenges

2M ago

Eisai Co. Reports Cautious Optimism Amid Q3 Growth

Company Announcements

Eisai Co. Reports Cautious Optimism Amid Q3 Growth

5M ago

ESALF Earnings this Week: How Will it Perform?

Biogen (NASDAQ:BIIB) and Eisai Win FDA’s OK on Alzheimer’s Drug Dosing

Pre-Earnings

ESALF Earnings this Week: How Will it Perform?

5M ago

PremiumMarket News

6M ago

Eisai Co (ESALF) Q2 Earnings Cheat Sheet

PremiumPre-Earnings

8M ago

PremiumMarket News

Eli Lilly’s Alzheimer’s Drug Could be Rejected by NHS

11M ago

LLY

ESALF Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

12M ago

PremiumGlobal MarketsJapanese Stocks: Eisai Shares Plummet as EU Rejects Alzheimer’s Drug

12M ago

Market News

Biogen (NASDAQ:BIIB) Ticks Up on New Alzheimer’s Drug in Japan

2y ago

Biogen, Eisai’s Alzheimer’s Drug Scores Big With FDA’s Full Approval

Market News

Biogen, Eisai’s Alzheimer’s Drug Scores Big With FDA’s Full Approval

2y ago

Eisai, Biogen say lecanemab received Priority Review status in Japan

PremiumThe Fly

2y ago

Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease

PremiumThe Fly

2y ago

Catalyst Pharmaceuticals completes acquisition of U.S. rights to FYCOMPA CII

PremiumThe Fly

2y ago

CPRX

PremiumMarket News

Biogen, Eisai May Have an Alzheimer’s Beater on Their Hands

3y ago